Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T72195 | Target Info | |||
Target Name | Annexin A5 (ANXA5) | ||||
Synonyms | Vascular anticoagulantalpha; Vascular anticoagulant-alpha; VACalpha; VAC-alpha; Thromboplastin inhibitor; Placental anticoagulant protein I; Placental anticoagulant protein 4; PP4; PAPI; PAP-I; Lipocortin V; Endonexin II; ENX2; Calphobindin I; CBPI; CBP-I; Annexin5; Annexin-5; Annexin V; Anchorin CII; ANX5 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | ANXA5 | ||||
Biochemical Class | Annexin protein | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: K201 free base | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLACENTAL ANNEXIN V COMPLEXED WITH K-201 AS A CALCIUM CHANNEL ACTIVITY INHIBITOR | PDB:1HAK | ||||
Method | X-ray diffraction | Resolution | 3.00 Å | Mutation | No | [1] |
PDB Sequence |
QVLRGTVTDF
12 PGFDERADAE22 TLRKAMKGLG32 TDEESILTLL42 TSRSNAQRQE52 ISAAFKTLFG 62 RDLLDDLKSE72 LTGKFEKLIV82 ALMKPSRLYD92 AYELKHALKG102 AGTNEKVLTE 112 IIASRTPEEL122 RAIKQVYEEE132 YGSSLEDDVV142 GDTSGYYQRM152 LVVLLQANRD 162 PDAGIDEAQV172 EQDAQALFQA182 GELKWGTDEE192 KFITIFGTRS202 VSHLRKVFDK 212 YMTISGFQIE222 ETIDRETSGN232 LEQLLLAVVK242 SIRSIPAYLA252 ETLYYAMKGA 262 GTDDHTLIRV272 MVSRSEIDLF282 NIRKEFRKNF292 ATSLYSMIKG302 DTSGDYKKAL 312 LLLCGEDD
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor. J Mol Biol. 1997 Nov 21;274(1):16-20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.